Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALPHAMAB-B

6.630
+0.0701.07%
Volume:1.60M
Turnover:10.58M
Market Cap:6.38B
PE:36.05
High:6.720
Open:6.640
Low:6.550
Close:6.560
Loading ...

HK Movers|HK Pharma Stocks Shined. Zai Lab Up 15%; HBM Up 10%; Remegen Up 9%; Alphamab And Wuxi Bio Up 5%.

Tiger Newspress
·
14 Apr

Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide

MT Newswires Live
·
09 Apr

Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs

MT Newswires Live
·
09 Apr

Alphamab Oncology Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
27 Mar

Alphamab Oncology FY Revenue RMB 640.1 Million

THOMSON REUTERS
·
25 Mar

Alphamab Oncology Says Jskn003 Granted Therapy Designation By NMPA

Reuters
·
18 Mar

Alphamab Oncology to Turn to 2024 Profit

MT Newswires Live
·
05 Mar

BUZZ-HK-listed Alphamab Oncology jumps on expectation of first annual profit

Reuters
·
05 Mar

BRIEF-Alphamab Oncology Sees Profit Of Not Less Than RMB150.0 Million For Year

Reuters
·
04 Mar

Alphamab Oncology - Expected Result Due to Three License Collaborations and Sales Revenue in FY

THOMSON REUTERS
·
04 Mar

Alphamab Oncology Sees Profit of Not Less Than RMB150.0 Mln for Year

THOMSON REUTERS
·
04 Mar

Market Participants Recognise Alphamab Oncology's (HKG:9966) Revenues Pushing Shares 88% Higher

Simply Wall St.
·
28 Feb

Even after rising 14% this past week, Alphamab Oncology (HKG:9966) shareholders are still down 78% over the past five years

Simply Wall St.
·
11 Feb

BRIEF-Alphamab Oncology Receives Approval From CDE China For JSKN003 To Initiate Phase III Clinical Study

Reuters
·
27 Dec 2024

Alphamab Oncology's Anti-Tumor Drug Gets NMPA's Nod for Phase III Clinical Trials

MT Newswires Live
·
27 Dec 2024

Alphamab Oncology - Approval From Cde China for Jskn003 to Initiate a Phase Iii- Clinical Study for Treatment of Oc

THOMSON REUTERS
·
27 Dec 2024

Alphamab Oncology's Anti-Tumor Drug Gets IND Approval from NMPA

MT Newswires Live
·
26 Dec 2024

Breakeven On The Horizon For Alphamab Oncology (HKG:9966)

Simply Wall St.
·
17 Dec 2024

Alphamab Oncology Presents Clinical Study Results for Tumor Treatment at Houston Cancer Meet

MT Newswires Live
·
11 Nov 2024

Alphamab Oncology Receives Waivers for Company Secretary from Hong Kong Bourse

MT Newswires Live
·
29 Oct 2024